IMAGENEBIO INC (IMA) Stock Income Statement
NASDAQ:IMA • US45175G2075
Current stock price
5.75 USD
-0.08 (-1.37%)
At close:
5.64 USD
-0.11 (-1.91%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 800.00K | 0.00 | 9.16M | 15.62M | 30.99M | |||
| Operating Expenses | 49.25M | 54.55M | 84.58M | 86.52M | 65.12M | |||
| Research and Development | 28.52M | 30.88M | 59.65M | 64.32M | 47.11M | |||
| Selling, General, and Administrative Expenses | 20.73M | 23.68M | 24.93M | 22.20M | 18.02M | |||
| Operating Income | -48.45M | -54.55M | -75.42M | -70.90M | -34.14M | |||
| Interest Income/Expense | 2.04M | 7.37M | 7.11M | 2.15M | N/A | |||
| Other Income/Expense | 717.00K | 2.52M | -22.00K | -10.00K | 20.00K | |||
| Non Recurring Items | N/A | -4.42M | N/A | N/A | N/A | |||
| Income Before Taxes | -45.70M | -49.08M | -68.33M | -68.77M | -34.12M | |||
| Income Tax | -350.00K | 152.00K | -162.00K | N/A | N/A | |||
| Net Income | -52.40M | -49.23M | -68.17M | -68.77M | -34.12M | |||
| EBITDA | -48.05M | -54.06M | -74.40M | -70.15M | -33.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.76 | -12.24 | -19.60 | -1.90 | -0.95 | |||
| Non GAAP EPS | -7.21 | -12.12 | -20.40 | -23.04 | -38.40 | |||
| Statistics | ||||||||
| Profit Margin | -6549.38% | N/A | -744.17% | -440.27% | -110.10% | |||
| Operating Profit Margin | -6056.38% | N/A | -823.33% | -453.91% | -110.16% | |||
All data in USD